at-003
Generic: bupivacaine liposome injectable suspension·Code: AT-003
at-003: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARATANA THERAPEUTICS, INC. (PETX) | Preclinical |
Get deeper analysis on at-003
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis